cyclosporine has been researched along with Adenocarcinoma in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 27 (57.45) | 18.2507 |
2000's | 13 (27.66) | 29.6817 |
2010's | 7 (14.89) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ferguson, J; Griffin, L; Keitley, J; Motta, L; Young, H | 1 |
Król, M; Majchrzak, K; Motyl, T; Mucha, J; Pawłowski, KM | 1 |
Hui, PP; Kai, S; Lu, JH; Zhao, H | 1 |
Jivrajani, M; Nivsarkar, M; Shaikh, MV; Shrivastava, N | 1 |
Campistol, JM; Canha, C; Castells, A; Diekmann, F; Ferreira, R; Moya-Rull, D; Oppenheimer, F; Revuelta, I; Rovira, J | 1 |
Grimm, M; Javadov, S; Kuznetsov, AV; Margreiter, R; Saks, V | 1 |
Beems, RB; de Vries, A; Luijten, M; Robinson, J; van Kesteren, PC; van Steeg, H | 1 |
Dahlem, C; Kollmar, O; Menger, MD; Rupertus, K; Schilling, MK | 1 |
Boffa, DJ; Hojo, M; Luan, FL; Maluccio, M; Suthanthiran, M | 1 |
Fukunaga, M; Gon, Y; Hashimoto, S; Mizumura, K; Sato, M; Takahashi, N; Tsujino, I | 1 |
Beijnen, JH; Boot, H; Kruijtzer, CM; Lochs, HL; Mathôt, RA; Parnis, FX; Pelgrims, JM; Planting, AS; Rosing, H; Schellens, JH; Schot, ME; Van Tinteren, H; Williams, R | 1 |
Mogayzel, PJ; Wagner, TL | 1 |
Baba, E; Katano, M; Matsunaga, H; Morisaki, T; Nakahara, C; Nakamura, K; Noshiro, H; Tanaka, M; Wada, M; Yamanaka, N | 1 |
Boffa, DJ; Lagman, M; Luan, F; Sharma, VK; Suthanthiran, M; Thomas, D; Yang, H | 1 |
Andrassy, J; Geissler, EK; Graeb, C; Guba, M; Jauch, KW; Koehl, GE; Kroemer, A; Richter, S; Scherer, MN; Schlitt, HJ; Steinbauer, M | 1 |
Black, JL; Borger, P; Burgess, JK; Glanville, AR; Hostettler, KE; Johnson, PR; Roth, M; Tamm, M | 1 |
Kobayashi, E; Murakami, T; Ohsawa, I; Uemoto, S | 1 |
Berlion, M; Dieterlen, A; Lucas, C; Marchal, S; Merlin, JL; Poullain, MG; Ramacci, C; Schultz, G | 1 |
Baroni, C; Bassi, C; Colombo, MP; Mastracchio, A; Melani, C; Parenza, M; Parmiani, G; Stoppacciaro, A | 1 |
Lucas, C; Marchal, S; Merlin, JL; Paraire, M; Poullain, MG; Ramacci, C | 1 |
Piontek, M; Porschen, R | 1 |
Harboe, M; Lea, T; Ostenstad, B; Schlichting, E; Sioud, M | 1 |
Augustijns, PF; Bradshaw, TP; Gan, LS; Hendren, RW; Thakker, DR | 1 |
Bischof, G; Cosentini, EP; Ellinger, A; Hamilton, G; Koperna, T; Riegler, M; Schweitzer, M; Teleky, B; Thalhammer, T; Zacherl, J | 1 |
Khanna, A; Li, B; Li, P; Suthanthiran, M | 1 |
De Bruijn, EA; Durante, NM; Eggermont, AM; Gheuens, EE; Marquet, RL; Van de Vrie, W; Van Oosterom, AT | 1 |
Baumgartner, G; Hamilton, G; Schirmböck, M; Sherwood, ER; Thalhammer, T; Theyer, G | 1 |
Delanian, S; Housset, M; Marie, JP; Maulard, C | 1 |
Chen, H; Yang, Q; Zhou, Y | 1 |
Andreeff, M; Angerler, J; Drach, J; Fiegl, M; Gsur, A; Haberl, I; Hamilton, G; Huber, H; Raderer, M; Zhao, S; Zojer, N | 1 |
Katayama, I; Nishioka, K; Yamamoto, T | 1 |
Bagshawe, KD; Sharma, SK | 1 |
Eggermont, AM; Marquet, RL; Van de Vrie, W | 1 |
Cohen, D; Kokubu, N; Watanabe, T | 1 |
Pollard, M | 1 |
Kashida, T; Naito, K; Narasaki, N; Sakai, A; Takeyama, S; Tsujihara, K; Tsuzurahara, K | 1 |
Haberl, I; Hamilton, G; Schaufler, K; Swatonek, H; Thalhammer, T; Theyer, G; Ulsperger, E; Wenzl, E | 1 |
Calvo Romero, JM; Puerto Pica, JM | 1 |
Hioki, K; Kameshita, I; Mohri, T; Suzuki, S; Takatani, S; Tokunaga, R | 1 |
Chan, MW; Chiang, CD; Song, EJ; Yang, VC | 1 |
Hosenpud, JD; Khanna, AK | 1 |
Chen, Z; Fei, H; He, Z; Liu, S; Shen, Z; Yuan, J | 1 |
Brown, AM; Murray, PI; Ramchandani, M; Rippin, JW | 1 |
Beijnen, JH; Duchin, K; Koopman, FJ; Lieverst, J; Malingré, MM; Rosing, H; Schellens, JH; Swart, M; ten Bokkel Huinink, WW; van Tellingen, O | 1 |
Cohen, D; Uchiyama-Kokubu, N; Watanabe, T | 1 |
Twentyman, PR; Wallace, HM; Wright, KA | 1 |
Baker, H; DeAngelis, B; Frank, O; Jyothirmayi, GN; Kabaria, V; Reddi, AS | 1 |
1 review(s) available for cyclosporine and Adenocarcinoma
Article | Year |
---|---|
Adenocarcinoma of the mouth in a patient with psoriasis under short-term cyclosporine therapy.
Topics: Adenocarcinoma; Cyclosporine; Drug Administration Schedule; Humans; Immunosuppressive Agents; Male; Middle Aged; Mouth Neoplasms; Psoriasis | 1996 |
2 trial(s) available for cyclosporine and Adenocarcinoma
Article | Year |
---|---|
Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer.
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Cyclosporine; Diarrhea; Drug Administration Schedule; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Neutropenia; Paclitaxel; Stomach Neoplasms; Treatment Outcome; Vomiting | 2003 |
The effect of different doses of cyclosporin A on the systemic exposure of orally administered paclitaxel.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Carcinoma, Small Cell; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasms; Paclitaxel; Premedication; Stomach Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms | 2001 |
44 other study(ies) available for cyclosporine and Adenocarcinoma
Article | Year |
---|---|
Disfiguring facial pyoderma vegetans with an excellent outcome.
Topics: Adenocarcinoma; Crohn Disease; Cyclosporine; Dermatologic Agents; Diagnosis, Differential; Facial Dermatoses; Female; Humans; Ileal Neoplasms; Laser Therapy; Middle Aged; Pyoderma | 2017 |
Canine mammary carcinoma cell line are resistant to chemosensitizers: verapamil and cyclosporin A.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cyclosporine; Dog Diseases; Dogs; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Animal; Verapamil; Vinblastine | 2014 |
Pre-clinical evaluation of cinobufotalin as a potential anti-lung cancer agent.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bufanolides; Cell Death; Cell Line, Tumor; Cell Survival; Cyclophilins; Cyclosporine; Drug Evaluation, Preclinical; Gene Expression Regulation, Neoplastic; Humans; Lactones; Lung Neoplasms; Male; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Peptidyl-Prolyl Isomerase F; RNA, Small Interfering; Spiro Compounds; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
An improved and versatile immunosuppression protocol for the development of tumor xenograft in mice.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Cyclophosphamide; Cyclosporine; Cytochrome P-450 CYP3A Inhibitors; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Ketoconazole; Male; Mice; Mice, Inbred C57BL; Xenograft Model Antitumor Assays | 2014 |
A case of esophageal adenocarcinoma on long-term rapamycin monotherapy.
Topics: Adenocarcinoma; Aged; Azathioprine; Biomarkers; Cyclosporine; Drug Substitution; Esophageal Neoplasms; Esophagectomy; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Neoplasm Proteins; Neoplasms, Second Primary; Phosphorylation; Postoperative Complications; Prednisone; Protein Processing, Post-Translational; Sarcoma, Kaposi; Signal Transduction; Sirolimus; Skin Neoplasms; TOR Serine-Threonine Kinases | 2015 |
Synchronism in mitochondrial ROS flashes, membrane depolarization and calcium sparks in human carcinoma cells.
Topics: Adenocarcinoma; Antioxidants; Breast Neoplasms; Calcium Signaling; Cell Line, Tumor; Colonic Neoplasms; Cyclosporine; Fluoresceins; Humans; Membrane Potential, Mitochondrial; Microscopy, Confocal; Microscopy, Fluorescence; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxidative Stress; Photochemistry; Reactive Oxygen Species; Recombinant Proteins; Rhodamines; Single-Cell Analysis; Superoxide Dismutase | 2017 |
DNA repair-deficient Xpa/p53 knockout mice are sensitive to the non-genotoxic carcinogen cyclosporine A: escape of initiated cells from immunosurveillance?
Topics: Adenocarcinoma; Animals; Biological Assay; Carcinogens; Cyclosporine; DNA Damage; Female; Lymphoma; Male; Mammary Neoplasms, Animal; Mice; Mice, Knockout; Mutagenicity Tests; Mutation; Precancerous Conditions; Tumor Suppressor Protein p53; Xeroderma Pigmentosum Group A Protein | 2009 |
Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Apoptosis; Cell Cycle; Cell Proliferation; Colorectal Neoplasms; Cyclosporine; Female; Hepatectomy; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; In Situ Nick-End Labeling; Liver Regeneration; Mice; Mice, Inbred BALB C; Mice, Nude; Microcirculation; Neovascularization, Pathologic; Protein Kinases; Sirolimus; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2009 |
Post-transplantation malignancy: a cell autonomous mechanism with implications for therapy.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Neoplasms; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, SCID; Neoplasm Invasiveness; Neoplasms; Organ Transplantation; Phenotype; Sirolimus; Tacrolimus | 2009 |
Cyclosporine A induces apoptosis of human lung adenocarcinoma cells via caspase-dependent pathway.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Blotting, Western; Caspases; Cell Line, Tumor; Cyclosporine; Cytochromes c; Cytosol; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Isoenzymes; Lung Neoplasms; Mitochondria | 2011 |
Cyclosporin and tacrolimus do not potentiate oxidative damage in pulmonary epithelial cells.
Topics: Adenocarcinoma; Cell Line, Tumor; Cell Survival; Cyclosporine; Humans; Hydrogen Peroxide; Lung Neoplasms; Oxidative Stress; Respiratory Mucosa; Tacrolimus | 2003 |
Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear factor-kappaB activation in human gastric carcinoma cells.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Caspase Inhibitors; Caspases; Chromatography, High Pressure Liquid; Colonic Neoplasms; Cyclosporine; Docetaxel; Drug Combinations; Enzyme Inhibitors; Female; Humans; Mice; Mice, Inbred BALB C; NF-kappa B; Peritoneal Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured | 2003 |
Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer.
Topics: Adenocarcinoma; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cyclosporine; Disease Progression; Drug Therapy, Combination; Humans; Immunosuppressive Agents; In Vitro Techniques; Lung Neoplasms; Male; Mice; Mice, Inbred DBA; Sirolimus; Tumor Cells, Cultured | 2004 |
Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Colonic Neoplasms; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, SCID; Sirolimus; Skin Neoplasms; Transplantation, Homologous | 2004 |
Cyclosporine A mediates fibroproliferation through epithelial cells.
Topics: Adenocarcinoma; Cell Division; Cell Line, Tumor; Culture Media, Conditioned; Cyclosporine; Fibroblasts; Humans; Immunosuppressive Agents; Lung Neoplasms; Respiratory Mucosa; Tacrolimus | 2004 |
In vivo luminescent imaging of cyclosporin A-mediated cancer progression in rats.
Topics: Adenocarcinoma; Animals; Benzamides; Blotting, Western; Cell Adhesion; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Cyclosporine; Dioxoles; Disease Progression; Gene Expression Regulation, Neoplastic; Image Processing, Computer-Assisted; Killer Cells, Natural; Liver Neoplasms; Luminescence; Lymphatic Metastasis; Male; Neoplasm Metastasis; Rats; Rats, Inbred F344; Receptors, Chemokine; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2006 |
Influence of S9788, a new modulator of multidrug resistance, on the cellular accumulation and subcellular distribution of daunorubicin in P-glycoprotein-expressing MCF7 human breast adenocarcinoma cells.
Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Nucleus; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Female; Flow Cytometry; Humans; Neoplasm Proteins; Piperidines; Subcellular Fractions; Triazines; Tumor Cells, Cultured; Verapamil | 1995 |
Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Cell Communication; Colonic Neoplasms; Cyclosporine; Granulocyte Colony-Stimulating Factor; Interferon-gamma; Mice; Mice, Inbred BALB C; Neutrophils; T-Lymphocytes; Transfection; Tumor Cells, Cultured | 1993 |
[Effect of the modality of exposure on the action of S9788 on the modulation of multidrug resistance of human tumor cell lines].
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Humans; Leukemia; Piperidines; Triazines; Tumor Cells, Cultured; Verapamil | 1994 |
Growth inhibition of human gastrointestinal cancer cells by cyclosporin A.
Topics: Adenocarcinoma; Cell Division; Colonic Neoplasms; Cyclosporine; Dose-Response Relationship, Drug; ErbB Receptors; Growth Inhibitors; Humans; Interleukin-2; Stomach Neoplasms; Tumor Cells, Cultured | 1994 |
Freshly isolated tumour-infiltrating T-lymphocytes have a high cytotoxic potential, as measured by their ability to induce apoptosis in the target cell.
Topics: Adenocarcinoma; Apoptosis; CD3 Complex; Colorectal Neoplasms; Cyclosporine; Cytotoxicity, Immunologic; DNA Damage; Humans; Immunity, Cellular; In Vitro Techniques; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating | 1995 |
Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport.
Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carrier Proteins; Cell Line; Cell Membrane; Chlorpromazine; Colonic Neoplasms; Cyclosporine; Drug Resistance; Humans; Kinetics; Membrane Glycoproteins; Progesterone; Tritium; Tumor Cells, Cultured | 1993 |
Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carrier Proteins; Cyclosporine; Cyclosporins; Depression, Chemical; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Hydrogen-Ion Concentration; Ileal Neoplasms; Ileocecal Valve; Membrane Glycoproteins; Neoplasm Proteins; Tumor Cells, Cultured; Verapamil; Vinblastine | 1994 |
Regulation of transforming growth factor-beta 1 (TGF-beta 1) expression with a novel TGF-beta 1 complementary DNA.
Topics: Adenocarcinoma; Base Sequence; Cell Line; Cyclosporine; DNA Replication; DNA, Complementary; Gene Expression Regulation, Neoplastic; Humans; Molecular Sequence Data; Oligonucleotides, Antisense; Organothiophosphates; Promoter Regions, Genetic; Transcription, Genetic; Transforming Growth Factor beta; Tumor Cells, Cultured | 1994 |
In vitro and in vivo chemosensitizing effect of cyclosporin A on an intrinsic multidrug-resistant rat colon tumour.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Colchicine; Colonic Neoplasms; Cyclosporine; Drug Resistance; Drug Synergism; Male; Membrane Glycoproteins; Neoplasm Proteins; Rats; Rats, Inbred Strains; Tumor Cells, Cultured; Verapamil | 1993 |
Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cell Division; Cyclosporine; Doxorubicin; Drug Resistance; Humans; Male; Membrane Glycoproteins; Phenotype; Prostatic Neoplasms; Rhodamine 123; Rhodamines; Tamoxifen; Tumor Cells, Cultured; Verapamil | 1993 |
Clinical effects on CA 15-3 level of cyclosporin A as a chemosensitiser in chemoresistant metastatic breast cancer.
Topics: Adenocarcinoma; Antigens, Tumor-Associated, Carbohydrate; Bone Neoplasms; Breast Neoplasms; Cyclosporine; Drug Resistance; Epirubicin; Female; Humans; Middle Aged | 1993 |
[Enhancement of antitumor effect of cisplatin on human ovarian cancer by cyclosporin A in vitro and in vivo].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cisplatin; Cyclosporine; Drug Synergism; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Tumor Cells, Cultured | 1996 |
Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes.
Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cyclosporine; Endocytosis; Humans; Ileal Neoplasms; Ileocecal Valve; Interferon-gamma; Interleukin-2; Interleukin-4; Lymphocyte Activation; Phytohemagglutinins; Recombinant Proteins; T-Lymphocytes; Tamoxifen; Tumor Cells, Cultured; Verapamil | 1996 |
Cyclosporine delays host immune response to antibody enzyme conjugate in ADEPT.
Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal; Antibody Formation; Colonic Neoplasms; Colorectal Neoplasms; Cyclosporine; gamma-Glutamyl Hydrolase; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Immunotherapy; Middle Aged; Pilot Projects; Prodrugs; Rectal Neoplasms | 1996 |
Cyclosporin A enhances locoregional metastasis of the CC531 rat colon tumour.
Topics: 1,2-Dimethylhydrazine; Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Carcinogens; Colonic Neoplasms; Cyclosporine; Dimethylhydrazines; Doxorubicin; Drug Resistance, Neoplasm; Immunosuppressive Agents; Male; Neoplasms, Experimental; Rats; Rats, Inbred Strains; Specific Pathogen-Free Organisms | 1997 |
Functional modulation of ATPase of P-glycoprotein by C219, a monoclonal antibody against P-glycoprotein.
Topics: Adenocarcinoma; Adenosine Triphosphatases; Adenosine Triphosphate; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Breast Neoplasms; Cell Line; Cell Membrane; Cyclosporine; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Kinetics; Tumor Cells, Cultured; Verapamil | 1997 |
Enhancement of metastasis of prostate adenocarcinoma cells by immune-suppressive cyclosporine A.
Topics: Adenocarcinoma; Animals; Cyclosporine; Immunosuppressive Agents; Lung Neoplasms; Lymphatic Metastasis; Male; Prostatic Neoplasms; Rats; Rats, Wistar; Specific Pathogen-Free Organisms | 1997 |
Study on the mechanism of immunopotentiating antitumor effect of 6-MPG, a water-soluble derivative of 6-mercaptopurine.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; Cyclosporine; Drug Interactions; Fibrosarcoma; Immunosuppressive Agents; Male; Mercaptopurine; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Phenotype; Solubility; Spleen; T-Lymphocytes; Water | 1997 |
P-glycoprotein-mediated multidrug resistance is modulated by pretreatment with chemosensitizers in HCT-8 carcinoma cells in vitro.
Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cyclosporine; Cyclosporins; Doxorubicin; Drug Resistance, Multiple; Epithelial Cells; Humans; Ileal Neoplasms; Ileocecal Valve; Kinetics; Phosphorylation; Rhodamine 123; Rhodamines; Tamoxifen; Tetradecanoylphorbol Acetate; Time Factors; Tumor Cells, Cultured; Verapamil; Vinblastine | 1998 |
[Gastric adenocarcinoma and kidney transplantation].
Topics: Adenocarcinoma; Adult; Carcinogens; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Stomach Neoplasms | 1998 |
Rapid adhesion and spread of non-adherent colon cancer Colo201 cells induced by the protein kinase inhibitors, K252a and KT5720 and suppression of the adhesion by the immunosuppressants FK506 and cyclosporin A.
Topics: Adenocarcinoma; Carbazoles; Cell Adhesion; Cell Adhesion Molecules; Colonic Neoplasms; Cyclosporine; Cytoskeletal Proteins; Enzyme Inhibitors; Extracellular Matrix; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Immunosuppressive Agents; Indole Alkaloids; Indoles; Integrins; Neoplasm Metastasis; Paxillin; Phosphoproteins; Phosphorylation; Protein Kinase C; Protein-Tyrosine Kinases; Pyrroles; Sulfonamides; Tacrolimus; Tumor Cells, Cultured; Tyrosine | 1998 |
Effects of cytoskeletal inhibitors on the accumulation of vincristine in a resistant human lung cancer cell line with high level of polymerized tubulin.
Topics: Adenocarcinoma; Cell Survival; Colchicine; Cyclosporine; Cytochalasin B; Cytochalasin D; Cytoskeleton; Drug Resistance, Neoplasm; Drug Synergism; Humans; Lung Neoplasms; Neoplasm Proteins; Paclitaxel; Tubulin; Tumor Cells, Cultured; Verapamil; Vincristine | 1998 |
Cyclosporine induces the expression of the cyclin inhibitor p21.
Topics: Adenocarcinoma; Antibodies; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Cyclosporine; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Lung Neoplasms; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes; Transfection; Transforming Growth Factor beta; Tumor Cells, Cultured | 1999 |
[Chemosensitivity test for 170 human breast carcinoma samples].
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cisplatin; Cyclosporine; Doxorubicin; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; Middle Aged; Paclitaxel; Tumor Cells, Cultured | 1998 |
Labial adenocarcinoma after treatment with cyclosporin a in a patient with panuveitis.
Topics: Adenocarcinoma; Aged; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lip Neoplasms; Panuveitis; Prednisolone; Retinal Diseases; Retinal Vessels; Vasculitis | 2000 |
Intracellular levels of two cyclosporin derivatives valspodar (PSC 833) and cyclosporin a closely associated with multidrug resistance-modulating activity in sublines of human colorectal adenocarcinoma HCT-15.
Topics: Adenocarcinoma; Anticarcinogenic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Division; Colorectal Neoplasms; Cyclosporine; Cyclosporins; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Inhibitory Concentration 50; Intracellular Fluid; Rhodamine 123; Tumor Cells, Cultured; Verapamil | 2001 |
Effects of cyclosporin A and a non-immunosuppressive analogue, O-acetyl cyclosporin A, upon the growth of parent and multidrug resistant human lung cancer cells in vitro.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Division; Cell Line; Cell Survival; Cyclosporine; Cyclosporins; Dose-Response Relationship, Drug; Drug Resistance; Eflornithine; Humans; In Vitro Techniques; Lung Neoplasms; Putrescine; Spermidine; Spermine | 1992 |
Vitamin and micronutrient concentrations in cyclosporine-induced renal tumor from diabetic rats.
Topics: Adenocarcinoma; Animals; Biopterins; Blood Glucose; Carnitine; Cyclosporine; Diabetes Mellitus, Experimental; Inositol; Kidney; Kidney Neoplasms; Male; Rats; Rats, Inbred Strains; Vitamins | 1991 |